Sulfacetamide/sulfur
| Combination of | |
|---|---|
| Sulfacetamide | Sulfonamide antibacterial |
| Sulfur (pharmacy) | Keratolytic |
| Clinical data | |
| AHFS/Drugs.com | Multum Consumer Information |
| License data | |
| Routes of administration | Topical |
| ATC code | |
| Legal status | |
| Legal status |
|
| (verify) | |
The drug combination sulfacetamide/sulfur is a topical acne medication[1] manufactured by Medicis under the trade name Plexion and also available under other trade names such as Clenia, Prascion, and Avar. It combines sodium sulfacetamide, a sulfonamide antibiotic, and sulfur, a keratolytic agent.[2] It is available in four formulations: as a cleansing cloth, cleanser, topical suspension, and as a facial mask. The sulfacetamide inhibits the growth of the bacterium Cutibacterium acnes that is associated with acne, while sulfur facilitates the removal of dead skin cells to prevent clogged pores.[3]
In 2023, it was the 311th most commonly prescribed medication in the United States, with more than 200,000 prescriptions.[4]
References
[edit]- ↑ Del Rosso JQ (January 2004). "Evaluating the role of topical therapies in the management of rosacea: focus on combination sodium sulfacetamide and sulfur formulations". Cutis. 73 (1 Suppl): 29–33. PMID 14959943.
- ↑ "Plexion (sodium sulfacetamide 10% and sulfur 5%)". Medicis Inc. Retrieved 2 December 2008.
- ↑ "Plexion Prescribing information" (PDF). Medicis. Archived from the original (PDF) on 20 September 2009. Retrieved 2 December 2008.
- ↑ "Sulfacetamide; Sulfur Drug Usage Statistics, United States, 2014 - 2023". ClinCalc. Retrieved 21 August 2025.
 | This dermatologic drug article is a stub. You can help Wikipedia by adding missing information. |